Bardiot; Dorothee Alice Marie-Eve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bardiot; Dorothee Alice Marie-Eve.The latest application filed is for "anti-viral compounds".

Company Profile

0.16.18

Bardiot; Dorothee Alice Marie-Eve - Leuven BE
Bardiot; Dorothee Alice Marie-Eve - Leuven Heverlee
Bardiot; Dorothee Alice Marie-Eve - Heverlee BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted indoline derivatives as dengue viral replication inhibitors Grant 11,407,715 - Bonfanti , et al. August 9, 2	2022-08-09
Anti-viral Compounds App 20220009903 - Vandyck; Koen ; et al.	2022-01-13
Substituted indoline derivatives as dengue viral replication inhibitors Grant 11,179,368 - Bardiot , et al. November 23, 2	2021-11-23
Substituted indoline derivatives as dengue viral replication inhibitors Grant 11,180,450 - Kesteleyn , et al. November 23, 2	2021-11-23
Substituted Indoline Derivatives As Dengue Viral Replication Inhibitors App 20210300868 - Bonfanti; Jean-Francois ; et al.	2021-09-30
Substituted indoline derivatives as dengue viral replication inhibitors Grant 11,083,707 - Kesteleyn , et al. August 10, 2	2021-08-10
Substituted indoline derivatives as dengue viral replication inhibitors Grant 11,053,196 - Bonfanti , et al. July 6, 2	2021-07-06
Mono- Or Di-substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20210171462 - Kesteleyn; Bart Rudolf Romanie ; et al.	2021-06-10
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 10,919,854 - Kesteleyn , et al. February 16, 2	2021-02-16
Substituted indoline derivatives as dengue viral replication inhibitors Grant 10,913,716 - Kesteleyn , et al. February 9, 2	2021-02-09
Substituted indoline derivatives as dengue viral replication inhibitors App 20200339511 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2020-10-29
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 10,786,484 - Kesteleyn , et al. September 29, 2	2020-09-29
Substituted Indoline Derivatives As Dengue Viral Replication Inhibitors App 20200299235 - Kesteleyn; Bart Rudolf Romanie ; et al.	2020-09-24
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 10,765,662 - Kesteleyn , et al. Sep	2020-09-08
Mono- Or Di-substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20200270209 - KESTELEYN; Bart Rudolf Romanie ; et al.	2020-08-27
Substituted indole compound derivatives as dengue viral replication inhibitors Grant 10,730,884 - Kesteleyn , et al.	2020-08-04
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 10,696,632 - Kesteleyn , et al. June 30, 2	2020-06-30
Substituted indoline derivatives as dengue viral replication inhibitors Grant 10,689,340 - Kesteleyn , et al.	2020-06-23
Substituted Indoline Derivatives As Dengue Viral Replication Inhibitors App 20200181083 - Bonfanti; Jean-Francois ; et al.	2020-06-11
Substituted indole derivatives as dengue viral replication inhibitors Grant 10,646,469 - Kesteleyn , et al.	2020-05-12
Substituted Indoline Derivatives As Dengue Viral Replication Inhibitors App 20200121647 - Kesteleyn; Bart Rudolf Romanie ; et al.	2020-04-23
Substituted Indoline Derivatives As Dengue Viral Replication Inhibitors App 20200054606 - Bardiot; Dorothee Alice Marie-Eve ; et al.	2020-02-20
Substituted indole compound derivatives as dengue viral replication inhibitors App 20190276467 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2019-09-12
Substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20190274999 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2019-09-12
Substituted indoline derivatives as dengue viral replication inhibitors App 20190112266 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2019-04-18
Mono- or di-substituted indoles as dengue viral replication inhibitors Grant 10,206,902 - Kesteleyn , et al. Feb	2019-02-19
Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20180346419 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2018-12-06
Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20180256545 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2018-09-13
Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20180256544 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2018-09-13
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 10,029,984 - Kesteleyn , et al. July 24, 2	2018-07-24
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Grant 9,944,598 - Kesteleyn , et al. April 17, 2	2018-04-17
Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors App 20180002282 - KESTELEYN; Bart Rudolf, Romanie ; et al.	2018-01-04
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors App 20170298017 - KESTELEYN; Bart Rudolf Romanie ; et al.	2017-10-19
Mono- or di-substituted indoles as dengue viral replication inhibitors App 20170224658 - Kesteleyn; Bart Rudolf Romanie ; et al.	2017-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.